Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01034101
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
HTA | N-[3-(N'-HYDROXYCARBOXAMIDO)-2- (2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE- N-METHYLAMIDE | A | 1FBL | 0.71 |  |
183 | 1-((2-HYDROXYETHOXY)METHYL)-5-(3- (BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)- DIONE | A,B,C,D,E,F | 1U1F | 0.71 | |
C27 | (6R)-2-amino-6-[2-(3'-methoxybiphenyl- 3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin- 4(3H)-one | A | 2VA7 | 0.75 | |
CZN | (2S,8R)-8-BENZYL-2-HYDROPEROXY- 6-(4-HYDROXYPHENYL)-2-(2-NAPHTHYLMETHYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHK | 0.73 | |
380 | (2R)-2-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO)- N-BENZYL-2-(3,4-DIMETHOXYPHENYL)ACETAMIDE | H,L | 1W2K | 0.72 | |
BIJ | 7-{[(2Z,5S)-5-CHLORO-2-{[2-METHOXY- 4-(4-METHYLPIPERAZIN-1-YL)PHENYL]IMINO}- 2,5-DIHYDROPYRIMIDIN-4-YL]AMINO}- 2-METHYL-2,3-DIHYDRO-1H-ISOINDOL- 1-ONE | A | 2JKO | 0.71 | |
DRR | A,B | 3BXR | 0.7 | | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGO | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E | 3CGL | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1G7K | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1GGX | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2ARL | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9I | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2VAD | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 2H8Q | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGP | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2IB5 | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOV | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOU | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2VAE | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2P4M | 0.71 | |
| CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9J | 0.71 | |
BRK | {(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]- 2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4- METHOXYPHENYL)METHANONE | A | 2IZR | 0.71 | |
CZI | (2R)-8-BENZYL-2-HYDROPEROXY-6-(4- HYDROXYPHENYL)-2-(4-IODOBENZYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHI | 0.76 | |
H24 | (6S)-2-amino-6-(3'-methoxybiphenyl- 3-yl)-3,6-dimethyl-5,6-dihydropyrimidin- 4(3H)-one | A | 2VA6 | 0.78 | |
L01 | 3-[({(1S,2R)-1-BENZYL-2-HYDROXY- 3-[(3-METHOXYBENZYL)AMINO]PROPYL}AMINO)(HYDROXY)METHYL]- N,N-DIPROPYLBENZAMIDE | A | 1W51 | 0.71 | |
401 | (2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]- 4-methoxybenzyl}butanoic acid | A,B | 2ZNQ | 0.7 | |
CZB | (2S,8R)-8-BENZYL-2-(4-BROMOBENZYL)- 2-HYDROPEROXY-6-(4-HYDROXYPHENYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHJ | 0.73 | |
CTA | CYCLOTHEONAMIDE A | A | 1TYN | 0.7 | |
D18 | 2,5-BIS{[4-(N-ISOPROPYL)DIAMINOMETHYL]PHENYL}FURAN | B | 298D | 0.71 | |
CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1QV1 | 0.75 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1JF2 | 0.75 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1SL9 | 0.75 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1JF0 | 0.75 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A | 1QV0 | 0.75 | |
| CZH | C2-HYDROPEROXY-COELENTERAZINE | A,B | 1EJ3 | 0.75 | |
CZP | (8R)-8-(CYCLOPENTYLMETHYL)-2-HYDROPEROXY- 2-(4-HYDROXYBENZYL)-6-(4-HYDROXYPHENYL)- 7,8-DIHYDROIMIDAZO[1,2-A]PYRAZIN- 3(2H)-ONE | A,B | 1UHH | 0.77 | |
L05 | 1-BENZYL-3-(4-METHOXYPHENYLAMINO)- 4-PHENYLPYRROLE-2,5-DIONE | A,B,C,D,E,F, G,H | 2ACL | 0.77 | |
D35 | 2,5-BIS{[4-(N-CYCLOHEXYLDIAMINOMETHYL)PHENYL]}FURAN | A | 1FMS | 0.7 | |
3MR | (4S)-4-(2-AMINO-6-PHENOXYQUINAZOLIN- 3(4H)-YL)-N,4-DICYCLOHEXYL-N-METHYLBUTANAMIDE | A | 2Q15 | 0.71 | |
4MP | 1-(4-METHOXYBENZOYL)-2-PYRROLIDINONE | A,B | 2AL5 | 0.7 | |
BPF | 2,5-BIS{[4-(N-ETHYLAMIDINO)]PHENYL}FURAN | A,B | 360D | 0.7 | |
CTZ | C2-HYDROXY-COELENTERAZINE | A | 2HPS | 0.76 | |
| CTZ | C2-HYDROXY-COELENTERAZINE | A | 1EL4 | 0.76 | |